Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Physicians with beliefs about long-term harms of benzodiazepine are less likely to prescribe it

Written by | 6 Dec 2022 | Mental Health

Despite the continuing growth of benzodiazepine (BZD)-related overdoses, BZD prescription rates have held constant. Much is unknown about how a doctor’s own beliefs about BZD use and potential harm to patients might influence their willingness to prescribe the drug. Using a Medicare database, researchers identified primary care providers who had prescribed a BZD in 2017 and surveyed a random sample of 100 doctors on their attitudes around BZD prescribing.

Approximately 62% of clinician respondents reported that they disagreed or strongly disagreed with the statement, “If a patient has been prescribed a benzodiazepine for years, the potential harms from continuing the benzodiazepine are low,” while 18.0% agreed or strongly agreed with the statement. When clinicians believed that the potential harms from continuing BZDs were low for patients on long-term treatment, they were more likely to prescribe a BZD to patients for whom they cared.

Linking a Survey of Clinician Benzodiazepine-related Beliefs to Risk of Benzodiazepine Prescription Fills Among Patients in Medicare

Donovan T. Maust, M.D., MS, et al
Department of Psychiatry and Institute for Healthcare Policy and Innovation, University of Michigan, and Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.